Hemab Therapeutics Holdings COAG
NASDAQ COAG
$40.86 +1.48 (+3.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Hemab Therapeutics Holdings (COAG) Income After Tax (2025 - 2026)

Updated

Hemab Therapeutics Holdings (COAG) posted Income After Tax of -$27.3 million for Q3 2026, compared with -$17.07 million a year earlier.

Analysis

Hemab Therapeutics Holdings (COAG) Income After Tax (2025 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Income After Tax at Hemab Therapeutics Holdings was -$91.21 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income After Tax (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 210.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 4.22 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.80 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 3.25 Bn
10 Hemab Therapeutics Holdings 1.91 Bn 672.70 Mn - -27.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -27.30 Mn
Jun 30, 2026 -24.15 Mn
Mar 31, 2026 -22.69 Mn
Sep 30, 2025 -17.07 Mn
Jun 30, 2025 -12.21 Mn
Mar 31, 2025 -15.31 Mn
API Access

Hemab Therapeutics Holdings Income After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=COAG&period=max&api_key=YOUR_API_KEY